SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp. engages in the design, manufacture, and launch of rockets and spacecrafts. It provides satellite communication services. The company was founded by Elon Reeve Musk on March 14, 2002 and is headquartered in Hawthorne, CA.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is currently trending as investors debate the massive valuation of its record-breaking IPO, with the community split between long-term bullish optimism for space infrastructure and bearish warnings regarding overvaluation and potential liquidity risks. While some retail traders are aggressively accumulating shares to hold for the future, others are actively scouting for entry points below IPO levels, waiting for the initial hype and volatility to settle.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Roku is seeing high volatility and intense community speculation following a recent report that the company is exploring a potential sale to a major media entity. Investors are actively debating the viability of a buyout versus a standalone growth strategy, with many weighing the companys platform dominance and recent profitability against ongoing market skepticism and competitive pressures.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk Corp (SNDK) is experiencing a parabolic rally driven by persistent AI-sector demand and institutional momentum, with the community actively debating whether the stock is in a sustainable growth phase or a speculative bubble. While some investors point to the stock's massive year-over-year gains and strong storage market fundamentals as justification for the run, many others are calling for a sharp correction, highlighting extreme RSI levels and the potential for a pullback as market liquidity shifts toward other major IPOs.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing high volatility as capital rotates into the major SpaceX IPO, leading investors to debate whether this decline is a temporary liquidity shakeout or a broader sector de-rating. The community remains focused on upcoming launch catalysts and the stock's long-term competitive position versus Starlink, with many viewing the sharp price pullback as a potential buying opportunity.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is facing intense volatility as the market reacts to the R2 delivery launch, with investors debating whether the stock is a long-term value play or a victim of persistent short-selling and poor execution. Community discussion is sharply divided between those cheering for the R2's product potential and those frustrated by the company's lack of transparent data and lackluster management of market expectations.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending as investors digest the DOJ's approval of its high-stakes acquisition of Warner Bros. Discovery, while the community intensely debates the potential for a mid-July deal closure and the impact of looming antitrust challenges from several U.S. states. The conversation is heavily focused on whether this merger will serve as the necessary catalyst to drive the share price upward or if ongoing regulatory hurdles and debt concerns will continue to suppress valuation.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health is currently experiencing significant bullish momentum driven by the expansion of its BetterHelp platform insurance coverage and a strategic partnership with Walmart, which investors see as a validator of its long-term telehealth infrastructure. The community is actively debating the potential for a short squeeze as high short interest persists alongside this positive fundamental shift, though long-term holders remain focused on the company's AI-driven scalability and role as a global leader in digital healthcare.

Entrepreneurshares Series Trust - ERShares Private-Public Crossover ETF

The ERShares Private-Public Crossover ETF (XOVR) is trending as investors debate its structure and valuation in relation to its significant exposure to SpaceX. While some community members are frustrated by the fund's recent price stagnation despite SpaceX's growth, others view it as an accessible, liquid entry point for pre-IPO space exposure compared to more volatile alternatives.

Tidal Trust II - Defiance Daily Target 2X Short ASTS ETF

ASTN is seeing significant volatility as traders leverage the ETF to play against the momentum of ASTS, which many investors view as a highly volatile meme stock. The community remains deeply divided, with bearish traders utilizing the 2X inverse ETF to bet on a correction while long-term bulls continue to debate the stock's valuation and potential for further gains.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech 100 is trending due to heightened volatility surrounding the SpaceX IPO, with investors debating whether the stock's recent decline is a result of capital rotation, dilution fears from an ATM offering, or the loss of a scarcity premium now that direct access to SpaceX is available. The community is actively discussing the fund's intrinsic value based on its holdings in high-profile AI and tech companies, with bulls viewing current levels as an oversold opportunity while bears express frustration over perceived management opacity and lack of communication.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lantern Pharma Announces Successful Outcome of FDA Type C Meeting Request for HARMONIC Phase 2 Trial of LP-300 in Never-Smokers with NSCLC

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage, AI-driven precision oncology company, today announced that it has received a successful response to its recent Type C meeting request from the...

Lantern Pharma Reports First Quarter 2026 Financial Results and Provides Business Updates

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage AI-driven precision oncology company leveraging its proprietary RADR artificial intelligence (AI) and machine learning (ML) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced operational...

Lantern Pharma Inc. Announces Closing of up to $9.25 Million Registered Direct Offering with Existing Holders and a Single Institutional Investor

Lantern Pharma Inc. (NASDAQ: LTRN) (Lantern or the Company), a clinical-stage AI-driven precision oncology company developing targeted and transformative cancer therapies using its proprietary AI and...

Lantern Pharma Inc. Announces up to $9.25 Million Registered Direct Offering with Existing Holders and a Single Institutional Investor

Lantern Pharma to Report First Quarter 2026 Operating & Financial Results on May 15th, 2026

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage AI-driven precision oncology company developing targeted and transformative cancer therapies using its proprietary AI and machine learning...

Lantern Pharma Unveils Roadmap for withZeta.ai Industry-First, Multi-Agentic Co-Scientist Featuring Swarm Intelligence and Computational Biology Toolkit with the Launch of ZetaSwarm and ZetaOmics

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage AI-driven precision oncology company, today unveiled the next phase of its development roadmap for withZeta.ai, the companys multi-agentic A.I...

Lantern Pharmas predictBBB.ai Evolves Into a Real-Time Large Quantitative Model (LQM) for Precision Molecular Intelligence Comprehensive Small Molecule Characterization & Development Analytics Available as a Web Service to Drug Developers Globally

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biotechnology company advancing precision oncology through its proprietary RADR AI platform, today announced the expansion of predictBBB.ai into a...

Lantern Pharma to Debut Public Demonstration of withZeta.ai - A Platform to Conquer Rare Cancers on April 30 Following AACR 2026 Scientific Debut

Lantern Pharma Inc. (NASDAQ: LTRN) (Lantern or the Company), an AI-driven clinical-stage precision oncology company, today announced the first public demonstration of withZeta.ai, its multi-agentic...

Emerging Data for Lantern Pharmas Investigational Drug LP-300 Demonstrates 8.3-Month Median Progression-Free Survival in Patients with EGFR L858R Lung Cancer After Targeted Therapy Failure With No Added Toxicity

Lantern Pharma Inc. (NASDAQ: LTRN), an AI-driven precision oncology company, today announced it has scheduled a Type C meeting with the U.S. Food and Drug Administration (FDA) for mid-May 2026 to...

Lantern Pharma Launches withZeta.ai the Worlds First Multi-Agentic A.I. Co-Scientist for Rare Cancer Drug Discovery & Development Subscriptions Now Open; Debut Events at Nasdaq MarketSite on 4/16 and at AACR 2026 from 4/17 to 4/22

Lantern Pharma Inc. (Nasdaq: LTRN) (Lantern or the Company), an AI-driven clinical-stage precision oncology company, today announced that withZeta.ai the worlds first and most comprehensive...

Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.

Current Price	$3.88
Prev Close	$4.07
Open	$4.05
Dividend Yield	0.00%
50-Day Moving Average	$2.70
Beta	1.94
Avg. Volume	316,310.51
PE Ratio	-2.82

52-Week High	$5.74
52-Week Low	$1.11
Market Capitalization	$46.01M
EPS (Annual)	-$1.57
Price to Book	13.29
Revenue Per Employee	$0.00

LTRNLantern Pharma Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LTRN News